U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C12H14N2O3
Molecular Weight 234.2512
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2-METHOXYIDAZOXAN

SMILES

COC1(COC2=C(O1)C=CC=C2)C3=NCCN3

InChI

InChIKey=HQGWKNGAKBPTBX-UHFFFAOYSA-N
InChI=1S/C12H14N2O3/c1-15-12(11-13-6-7-14-11)8-16-9-4-2-3-5-10(9)17-12/h2-5H,6-8H2,1H3,(H,13,14)

HIDE SMILES / InChI

Molecular Formula C12H14N2O3
Molecular Weight 234.2512
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
0.62 nM [Kd]
3.83 nM [Kd]
1.78 nM [Kd]
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:30:36 GMT 2023
Edited
by admin
on Sat Dec 16 08:30:36 GMT 2023
Record UNII
E27LB7P0ET
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
2-METHOXYIDAZOXAN
Common Name English
1H-IMIDAZOLE, 2-(2,3-DIHYDRO-2-METHOXY-1,4-BENZODIOXIN-2-YL)-4,5-DIHYDRO-
Systematic Name English
2-(2,3-DIHYDRO-2-METHOXY-1,4-BENZODIOXIN-2-YL)-4,5-DIHYDRO-1H-IMIDAZOLE
Systematic Name English
RX-821002
Code English
2-METHOXYIDAZOXAN, (±)-
Common Name English
Code System Code Type Description
CHEBI
73287
Created by admin on Sat Dec 16 08:30:36 GMT 2023 , Edited by admin on Sat Dec 16 08:30:36 GMT 2023
PRIMARY
CAS
102575-24-6
Created by admin on Sat Dec 16 08:30:36 GMT 2023 , Edited by admin on Sat Dec 16 08:30:36 GMT 2023
PRIMARY
FDA UNII
E27LB7P0ET
Created by admin on Sat Dec 16 08:30:36 GMT 2023 , Edited by admin on Sat Dec 16 08:30:36 GMT 2023
PRIMARY
EPA CompTox
DTXSID00907762
Created by admin on Sat Dec 16 08:30:36 GMT 2023 , Edited by admin on Sat Dec 16 08:30:36 GMT 2023
PRIMARY
PUBCHEM
108094
Created by admin on Sat Dec 16 08:30:36 GMT 2023 , Edited by admin on Sat Dec 16 08:30:36 GMT 2023
PRIMARY
Related Record Type Details
LABELED -> NON-LABELED
ENANTIOMER -> RACEMATE
TARGET -> INHIBITOR
BINDING
IC50
TARGET -> INHIBITOR
IC50
ENANTIOMER -> RACEMATE